Noticias

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

15 Febrero, 2018

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Accesos directos